Free Trial

11,679 Shares in Grail, Inc. (NASDAQ:GRAL) Acquired by Treasurer of the State of North Carolina

Grail logo with Medical background

Treasurer of the State of North Carolina acquired a new position in Grail, Inc. (NASDAQ:GRAL - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 11,679 shares of the company's stock, valued at approximately $208,000.

A number of other hedge funds have also recently bought and sold shares of GRAL. FNY Investment Advisers LLC acquired a new position in shares of Grail in the 4th quarter worth approximately $26,000. Lindbrook Capital LLC bought a new stake in shares of Grail during the 4th quarter valued at $28,000. Wellington Shields Capital Management LLC acquired a new position in shares of Grail in the 4th quarter valued at $33,000. New York State Common Retirement Fund acquired a new stake in shares of Grail during the fourth quarter worth $59,000. Finally, Wilmington Savings Fund Society FSB bought a new stake in Grail in the fourth quarter valued at about $64,000.

Insider Buying and Selling at Grail

In related news, President Joshua J. Ofman sold 2,109 shares of the firm's stock in a transaction on Friday, March 7th. The shares were sold at an average price of $31.20, for a total value of $65,800.80. Following the completion of the transaction, the president now directly owns 559,673 shares of the company's stock, valued at approximately $17,461,797.60. This trade represents a 0.38 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Aaron Freidin sold 1,816 shares of Grail stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $31.20, for a total transaction of $56,659.20. Following the completion of the transaction, the chief financial officer now directly owns 335,170 shares of the company's stock, valued at approximately $10,457,304. This trade represents a 0.54 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 11,550 shares of company stock worth $360,436 over the last ninety days.

Grail Price Performance

NASDAQ GRAL traded up $1.90 on Thursday, reaching $35.66. The company had a trading volume of 380,729 shares, compared to its average volume of 1,221,455. The company's fifty day moving average is $31.69 and its 200-day moving average is $23.92. Grail, Inc. has a 1-year low of $12.33 and a 1-year high of $63.99.

Grail (NASDAQ:GRAL - Get Free Report) last issued its quarterly earnings results on Thursday, February 20th. The company reported ($1.86) earnings per share (EPS) for the quarter, beating the consensus estimate of ($4.41) by $2.55. The business had revenue of $38.25 million during the quarter, compared to analyst estimates of $35.33 million. Research analysts predict that Grail, Inc. will post -15.15 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on GRAL. Canaccord Genuity Group started coverage on Grail in a research note on Monday. They issued a "buy" rating and a $32.00 price target for the company. Morgan Stanley raised their price target on Grail from $16.00 to $20.00 and gave the stock an "equal weight" rating in a research report on Tuesday, March 18th.

Check Out Our Latest Report on Grail

Grail Company Profile

(Free Report)

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.

See Also

Institutional Ownership by Quarter for Grail (NASDAQ:GRAL)

Should You Invest $1,000 in Grail Right Now?

Before you consider Grail, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Grail wasn't on the list.

While Grail currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Stocks Offering Rare Generational Buying Opportunities
Make Your Money Work Harder: The Power of Dividend Investing
7 Cybersecurity Stocks Outperforming the Market Right Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines